NHIQ Stock Overview
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
NantHealth, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.34 |
52 Week High | US$3.79 |
52 Week Low | US$0.20 |
Beta | 1.59 |
1 Month Change | -38.00% |
3 Month Change | -5.28% |
1 Year Change | -78.73% |
3 Year Change | -99.15% |
5 Year Change | -96.77% |
Change since IPO | -99.88% |
Recent News & Updates
Recent updates
Investors Aren't Buying NantHealth, Inc.'s (NASDAQ:NH) Revenues
Apr 17NantHealth GAAP EPS of -$0.11, revenue of $16.5M
Aug 04Ronald Louks Is The Chief Operating Officer of NantHealth, Inc. (NASDAQ:NH) And They Just Sold 26% Of Their Shares
Mar 18Time To Worry? Analysts Are Downgrading Their NantHealth, Inc. (NASDAQ:NH) Outlook
Mar 06If You Had Bought NantHealth (NASDAQ:NH) Shares A Year Ago You'd Have Earned 183% Returns
Feb 04NantHealth jumps after study highlights the utility of its decision-support platform
Dec 11Shareholder Returns
NHIQ | US Healthcare Services | US Market | |
---|---|---|---|
7D | -27.7% | -5.9% | -3.7% |
1Y | -78.7% | -11.5% | 20.5% |
Return vs Industry: NHIQ underperformed the US Healthcare Services industry which returned -11.5% over the past year.
Return vs Market: NHIQ underperformed the US Market which returned 20.5% over the past year.
Price Volatility
NHIQ volatility | |
---|---|
NHIQ Average Weekly Movement | 52.9% |
Healthcare Services Industry Average Movement | 10.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NHIQ's share price has been volatile over the past 3 months.
Volatility Over Time: NHIQ's weekly volatility has increased from 38% to 53% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 373 | Rao Naseem | nanthealth.com |
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans, and centers for medicare and medicaid services for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks.
NantHealth, Inc. Fundamentals Summary
NHIQ fundamental statistics | |
---|---|
Market cap | US$11.12m |
Earnings (TTM) | -US$70.37m |
Revenue (TTM) | US$64.27m |
0.2x
P/S Ratio-0.2x
P/E RatioIs NHIQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NHIQ income statement (TTM) | |
---|---|
Revenue | US$64.27m |
Cost of Revenue | US$23.37m |
Gross Profit | US$40.90m |
Other Expenses | US$111.28m |
Earnings | -US$70.37m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.16 |
Gross Margin | 63.64% |
Net Profit Margin | -109.49% |
Debt/Equity Ratio | -108.8% |
How did NHIQ perform over the long term?
See historical performance and comparison